Related Experiment Videos
Antineutrophil cytoplasmic antibodies in diffuse panbronchiolitis.
1Department of Pulmonary Medicine, Jichi Medical School, Tochigi, Japan.sugiyuki@jichi.ac.jp
Respiration; International Review of Thoracic Diseases
|June 12, 1999
Summary
Myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) were detected in some patients with diffuse panbronchiolitis. This suggests a potential link between this chronic lung disease and vasculitis.
Area of Science:
- Pulmonology
- Immunology
- Rheumatology
Background:
- Chronic suppurative lung diseases like cystic fibrosis can coexist with systemic vasculitis.
- Diffuse panbronchiolitis shares features with chronic sinopulmonary infections and respiratory bronchiolitis.
Purpose of the Study:
- To investigate the presence of myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with diffuse panbronchiolitis.
- To explore potential associations between MPO-ANCA and diffuse panbronchiolitis.
Main Methods:
- Serum samples were collected from 30 patients diagnosed with diffuse panbronchiolitis.
- Serum samples from 57 patients with other pulmonary diseases served as a control group.
- Myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) titers were measured in all participants.
Main Results:
- MPO-ANCA positivity was identified in 4 out of 30 patients with diffuse panbronchiolitis.
- No MPO-ANCA positivity was observed in the control group of patients with other pulmonary diseases.
Conclusions:
- MPO-ANCA can be present in a subset of patients suffering from diffuse panbronchiolitis.
- The findings highlight the importance of considering vasculitis in patients presenting with chronic pulmonary infections like diffuse panbronchiolitis.